TRANG PHAN: Open Payments
NPI 1891094611 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 40 payments from 12 companies in 2025. Trend: 2023 $124 · 2024 $678 · 2025 $1,904
Food & beverage: $1,004Consulting: $900
| Company | Payments | Amount |
|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $1,006 |
| ABBVIE INC. | 8 | $221 |
| GENZYME CORPORATION | 6 | $169 |
| Janssen Biotech, Inc. | 5 | $119 |
| Incyte Corporation | 4 | $93 |
| Galderma Laboratories, L.P. | 3 | $68 |
| Amgen Inc. | 3 | $61 |
| LEO Pharma Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| UCB, Inc. | 1 | $31 |
Products named: Cabtreo, DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, OPZELURA, NEMLUVIO, Otezla.
Industry payments across CA — which companies pay providers there.
